{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:49:50Z","timestamp":1790027390176,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcp.2018.01.013","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T12:45:23Z","timestamp":1515156323000},"page":"288-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro"],"prefix":"10.1016","volume":"148","author":[{"given":"Ankita","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hobby","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Dhankani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Prakash","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Barthwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Farndale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2018.01.013_b0005","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1111\/jth.12947","article-title":"Antiplatelet drugs: which targets for which treatments?","volume":"13","author":"Gachet","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcp.2018.01.013_b0010","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.drudis.2014.06.005","article-title":"New advances in treating thrombotic diseases: GPVI as a platelet drug target","volume":"19","author":"Jiang","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2018.01.013_b0015","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1096\/fj.04-2748com","article-title":"Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI","volume":"19","author":"Penz","year":"2005","journal-title":"Faseb J."},{"key":"10.1016\/j.bcp.2018.01.013_b0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00395-008-0722-3","article-title":"Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo","volume":"103","author":"Schulz","year":"2008","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2018.01.013_b0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1468-1331.2009.02754.x","article-title":"Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke","volume":"17","author":"Bigalke","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bcp.2018.01.013_b0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1538-7836.2009.03659.x","article-title":"Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication","volume":"8","author":"Stellos","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcp.2018.01.013_b0035","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","article-title":"Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb\/IIIa blockade on infarct size, functional outcome, and intracranial bleeding","volume":"115","author":"Kleinschnitz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2018.01.013_b0040","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.110.980623","article-title":"Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans","volume":"123","author":"Ungerer","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2018.01.013_b0045","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.5301\/heartint.5000229","article-title":"Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke","volume":"11","author":"Reimann","year":"2016","journal-title":"Heart Int."},{"key":"10.1016\/j.bcp.2018.01.013_b0050","doi-asserted-by":"crossref","first-page":"e0128744","DOI":"10.1371\/journal.pone.0128744","article-title":"Inhibition of glycoprotein VI clustering by collagen as a mechanism of inhibiting collagen-induced platelet responses: the example of losartan","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2018.01.013_b0055","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cardiores.2007.05.005","article-title":"Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies","volume":"75","author":"Hsiao","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2018.01.013_b0060","first-page":"615","article-title":"A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation","volume":"69","author":"Zhou","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.bcp.2018.01.013_b0065","doi-asserted-by":"crossref","first-page":"40002","DOI":"10.1038\/srep40002","article-title":"Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: functional ex vivo and in vivo studies","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2018.01.013_b0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/09537104.2013.863856","article-title":"Hinokitiol is a novel glycoprotein VI antagonist on human platelets","volume":"25","author":"Lu","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.bcp.2018.01.013_b0075","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bcp.2013.02.027","article-title":"Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo","volume":"85","author":"Lin","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.013_b0080","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/acs.jmedchem.6b01360","article-title":"Novel glycoprotein VI antagonists as antithrombotics: synthesis, biological evaluation, and molecular modeling studies on 2,3-disubstituted tetrahydropyrido(3,4-b)indoles","volume":"60","author":"Bhunia","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.013_b0085","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1182\/blood-2011-06-360743","article-title":"Critical role for Syk in responses to vascular injury","volume":"118","author":"Andre","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.01.013_b0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejphar.2007.11.009","article-title":"Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets","volume":"580","author":"Bhavaraju","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.013_b0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jth.13613","article-title":"Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets","volume":"15","author":"Poulter","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcp.2018.01.013_b0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/09537104.2016.1227062","article-title":"Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool","volume":"28","author":"Chatterjee","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.bcp.2018.01.013_b0105","unstructured":"D. Dikshit, M. Dikshit, T. Siddiqi, A. Kumar, R. Bhatta, G. Jain, et al., Chiral 3-aminomethylpiperidine derivatives as inhibitors of collagen induced platelet activation and adhesion, 2012, PCT\/IN2012\/000032: WO2012104866 A1."},{"key":"10.1016\/j.bcp.2018.01.013_b0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejmech.2014.05.017","article-title":"Synthesis and identification of chiral aminomethylpiperidine carboxamides as inhibitor of collagen induced platelet activation","volume":"81","author":"Anil Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.013_b0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/dta.1811","article-title":"Assessement of the pharmacokinetics, tissue distribution and excretion studies of a novel antiplatelet agent S007-867, following administration to rats","volume":"8","author":"Chandasana","year":"2016","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.bcp.2018.01.013_b0120","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/00498254.2014.994053","article-title":"Pharmacokinetics and tissue distribution study of novel potent antiplatelet agent S007-867 in mice using HPLC-MS\/MS","volume":"45","author":"Chandasana","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.01.013_b0125","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1074\/jbc.M509818200","article-title":"Use of synthetic peptides to locate novel integrin alpha2beta1-binding motifs in human collagen III","volume":"281","author":"Raynal","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.01.013_b0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.thromres.2005.12.011","article-title":"Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio\u2013venous shunt thrombosis in vivo","volume":"118","author":"Tohti","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcp.2018.01.013_b0135","article-title":"Optimization of ferric chloride induced thrombosis model in rats: effect of anti-platelet and anti-coagulant drugs","author":"Surin","year":"2009","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bcp.2018.01.013_b0140","first-page":"e52838","article-title":"Ferric chloride-induced thrombosis mouse model on carotid artery and mesentery vessel","author":"Bonnard","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bcp.2018.01.013_b0145","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1182\/blood-2002-05-1470","article-title":"Protection against thrombosis in mice lacking PAR3","volume":"100","author":"Weiss","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.01.013_b0150","doi-asserted-by":"crossref","DOI":"10.3791\/54479-v","article-title":"Ferric chloride-induced murine thrombosis models","author":"Li","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bcp.2018.01.013_b0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamasurg.2014.1685","article-title":"Development and validation of 4 different rat models of uncontrolled hemorrhage","volume":"150","author":"Morgan","year":"2015","journal-title":"JAMA Surg."},{"key":"10.1016\/j.bcp.2018.01.013_b0160","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/j.1538-7836.2012.04859.x","article-title":"Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P\/N) in a rabbit model","volume":"10","author":"Pragst","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcp.2018.01.013_b0165","doi-asserted-by":"crossref","DOI":"10.3791\/53930-v","article-title":"TAPE: a biodegradable hemostatic glue inspired by a ubiquitous compound in plants for surgical application","author":"Kim","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bcp.2018.01.013_b0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1179\/1351000213Y.0000000057","article-title":"Phospholipase C-gamma2 via p38 and ERK1\/2 MAP kinase mediates diperoxovanadate-asparagine induced human platelet aggregation and sCD40L release","volume":"18","author":"Misra","year":"2013","journal-title":"Redox Rep."},{"key":"10.1016\/j.bcp.2018.01.013_b0175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200208043","article-title":"Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2","volume":"160","author":"Inoue","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2018.01.013_b0180","article-title":"Differential integrin activity mediated by platelet collagen receptor engagement under flow conditions","author":"Pugh","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2018.01.013_b0185","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1182\/blood-2010-01-260778","article-title":"Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood","volume":"115","author":"Pugh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.01.013_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.01.019","article-title":"Synthesis and evaluation of dual antiplatelet activity of bispidine derivatives of N-substituted pyroglutamic acids","volume":"110","author":"Misra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.01.013_b0195","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.01.013_b0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0038-1646657","article-title":"Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats","volume":"39","author":"Umetsu","year":"1978","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2018.01.013_b0205","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood-2005-09-3687","article-title":"Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo","volume":"107","author":"Dubois","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.01.013_b0210","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood-2013-09-521484","article-title":"Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and alpha2beta1-mediated collagen binding in thrombus formation","volume":"124","author":"Shida","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.01.013_b0215","first-page":"969","article-title":"Platelet adhesion receptors and (patho)physiological thrombus formation","volume":"16","author":"Andrews","year":"2001","journal-title":"Histol. Histopathol."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2018.10.025","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:00:17Z","timestamp":1757768417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218300133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":43,"alternative-id":["S0006295218300133"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.013","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bcp.2018.10.025","asserted-by":"object"}]},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}